Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Pulmonx Corp - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
LUNG
Nasdaq
3841
https://pulmonx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Pulmonx Corp
Q1 2023 Pulmonx Corp Earnings Call
- May 3rd, 2023 2:43 pm
Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates
- May 2nd, 2023 9:35 pm
Pulmonx Reports First Quarter 2023 Financial Results
- May 2nd, 2023 8:05 pm
7 Nasdaq Small-Cap Stocks Set to Outperform in 2023
- Apr 28th, 2023 12:24 am
Pulmonx to Present at the Bank of America Securities 2023 Health Care Conference
- Apr 25th, 2023 8:05 pm
Pulmonx to Report First Quarter 2023 Financial Results on May 2, 2023
- Apr 18th, 2023 8:05 pm
Pulmonx Corporation (NASDAQ:LUNG) Not Flying Under The Radar
- Apr 17th, 2023 6:20 pm
Why Shares of Pulmonx Rose This Week
- Feb 24th, 2023 9:00 pm
Pulmonx Corporation (LUNG) Reports Q4 Loss, Tops Revenue Estimates
- Feb 22nd, 2023 10:55 pm
Pulmonx Reports Fourth Quarter and Full Year 2022 Financial Results
- Feb 22nd, 2023 9:05 pm
Pulmonx to Present at the Citi 2023 Healthcare Conference
- Feb 16th, 2023 9:05 pm
Pulmonx to Report Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023
- Feb 8th, 2023 9:05 pm
Pulmonx (NASDAQ:LUNG) investors are sitting on a loss of 66% if they invested a year ago
- Jan 31st, 2023 11:57 am
American Lung Association Campaign Shines Spotlight on Endobronchial Valves for Advanced COPD/Emphysema
- Dec 14th, 2022 9:05 pm
Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema
- Nov 30th, 2022 12:00 pm
Pulmonx to Present at the 34th Annual Piper Sandler Healthcare Conference
- Nov 16th, 2022 9:05 pm
Pulmonx Corporation (NASDAQ:LUNG) Analysts Just Slashed Next Year's Revenue Estimates By 21%
- Nov 11th, 2022 10:12 am
Pulmonx Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag
- Nov 9th, 2022 11:27 am
Why Pulmonx Stock Is Crashing Today
- Nov 4th, 2022 4:34 pm
Pulmonx to Participate at Upcoming Investor Conferences
- Nov 4th, 2022 12:00 pm
Scroll